In addition, the planners and instructors listed have agreed that all recommendations involving clinical medicine  will be based on evidence that is generally accepted within the profession as adequate justification for their indications and contraindications in the care of patients; that all scientific research used in support or justification  of a patient care recommendation will conform to the generally accepted standards of experimental design, data  collection and analysis; and that material to be presented will be made available for advance peer review if requested.

Faculty

DANIEL CLAUW, M.D.
Consultant, Abbott, Cerephex, Eli Lilly, Forest Laboratories, Johnson & Johnson, Merck, Pfizer, Purdue, Samumed, Theravance, Tonix, UCB, Zynerba.
Advisory Strategic, Abbot, Astellas, Cerephex, Eli Lilly, Forest Laboratories, Johnson & Johnson, Pfizer, Purdue, Zynerba.
Science or Medical Board, Abbot, Astella, Cerephex, Eli Lilly, Forest Laboratories, Johnson & Johnson, Pfizer Purdue
Expert Witness, Eli Lilly, Forest Laboratories, Johnson & Johnson, Pfizer, Williams & Connolly

PROGRAM PLANNING COMMITTEE

 Susan Hardin has disclosed no relevant financial relationships with any commercial interests.